Circulating Immune Complexes and Complement Activation in Sensitized Kidney Transplant Recipients
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252010904 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Maria Stella Trivyza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Kidney Transplantation, University Hospital of Patras, 26504 Patras, Greece. Hauptthemen laut MEDLINE: Kidney Transplantation, Antigen-Antibody Complex, Complement C1q, Complement Activation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Research Council of the University of Patras.
Abstract (Originalsprache)
Chronic antibody-mediated rejection in kidney transplantation is a common cause of graft loss in the late post-transplant period. In this process, the role of the classical complement activation pathway is crucial due to the formation of immune complexes between donor-specific antibodies (DSAs) and donor antigens and the attachment of the C1q complement fragment. This study aimed to determine the levels of circulating C1q immunocomplexes (CIC-C1q) and complement activation (CH50), in sensitized kidney transplant recipients (KTRs). In this cross-sectional study we used serum samples from KTRs with de novo or preformed DSAs (n = 14), KTRs without DSAs (n = 28), and 22 subjects with no history of chronic kidney disease (controls). C1q immunocomplexes and CH50 concentration in serum were measured with the enzyme immunoassay (EIA) kit MicroVue CIC-C1q (Quidel, Athens, OH, USA) and EIA kit MicroVue CH50 (Quidel, OH, USA), respectively. Higher concentrations of CIC-C1q was observed in KTRs with DSAs in comparison with controls and with KTRs with no DSAs (6.8 ± 2.7 and 4.8 ± 1.9 vs. 5.0 ± 1.2 μg Eq/mL, respectively, p < 0.01). We found no difference in CIC-C1q between KTRs with no DSAs and controls. CIC-C1q levels were positively correlated with DSA titer. CH50 levels were decreased in KTRs with DSAs in comparison with controls and KTRs with no DSAs (39 ± 15 vs. 68 ± 40 and 71 ± 34 U Eq/mL, respectively, p < 0.01). There was no difference in CH50 between DSA-negative KTRs and controls. Kidney transplant recipients with DSAs had increased serum levels of C1q immunocomplexes and increased classical pathway complement activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Kidney Transplantation, University Hospital of Patras, 26504 Patras, Greece.
- Laboratory of Biology, Department of Biology, University of Patras, 26504 Patras, Greece.
- Department of Surgery, University Hospital of Patras, 26504 Patras, Greece.
ORCID-Profile: Sotiris Tsakas, Marios Papasotiriou, Nikolaos Karydis, Evangelos Papachristou
Förderung
- the Research Council of the University of Patras
Zitieren
APA
Trivyza, M. S., Stergiopoulou, C., Tsakas, S., Ntrinias, T., Papasotiriou, M., Karydis, N., Papachristou, E., & Goumenos, D. S. (2024). Circulating Immune Complexes and Complement Activation in Sensitized Kidney Transplant Recipients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252010904
Vancouver
Trivyza MS, Stergiopoulou C, Tsakas S, Ntrinias T, Papasotiriou M, Karydis N, et al. Circulating Immune Complexes and Complement Activation in Sensitized Kidney Transplant Recipients. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252010904
BibTeX
@article{Trivyza2024,
author = {Trivyza, Maria Stella and Stergiopoulou, Charikleia and Tsakas, Sotiris and Ntrinias, Theodoros and Papasotiriou, Marios and Karydis, Nikolaos and Papachristou, Evangelos and Goumenos, Dimitrios S},
title = {Circulating Immune Complexes and Complement Activation in Sensitized Kidney Transplant Recipients},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252010904}
}
EUVIMED